MedTrace Logo

Prediction of Chronic Pain by the Pain Monitor

NCT01595711 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2018-01-29

No results posted yet for this study

Summary

The skin conductance algesimeter (Pain Monitor™, Med-Storm Innovation AS, NO-0264 Oslo, Norway)) reflects the sympathetic nervous system by the measurement of the skin conductance of the palm of the hand. SCA detects nociceptive pain fast and continuously, specific to the individual, with higher sensitivity and specificity than other available objective methods.

The skin conductance response to a calibrated noxious stimulus varies among patients. It defines two types of people depending on its magnitude.

The investigators assume that the importance of skin conductance response to a noxious stimulus predicts the occurrence of chronic pain in patients operated by thoracotomy.

Conditions

  • Surgery

Interventions

DEVICE

Pain Monitor

Measurement of cutaneous conductance

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Morgan Le Guen, MD · Hopital Foch

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-07
Primary Completion
2013-09-07
Completion
2013-09-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01595711 on ClinicalTrials.gov